These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Perspectives in immunoregulation and autoimmunity. Cruse JM; Lewis RE Concepts Immunopathol; 1986; 3():1-16. PubMed ID: 3496159 [No Abstract] [Full Text] [Related]
25. B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target. Dalakas MC Pharmacol Ther; 2006 Oct; 112(1):57-70. PubMed ID: 16644016 [TBL] [Abstract][Full Text] [Related]
27. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides. Atassi MZ; Oshima M Crit Rev Immunol; 1997; 17(5-6):481-95. PubMed ID: 9419435 [TBL] [Abstract][Full Text] [Related]
29. Cord blood contains high numbers of autoimmune T cells recognizing multiple myelin proteins and acetylcholine receptor. Fredrikson S; Sun JB; Huang WX; Li BL; Olsson T; Link H J Immunol; 1993 Aug; 151(4):2217-24. PubMed ID: 8345205 [TBL] [Abstract][Full Text] [Related]
30. Immunoregulation by Vbeta specific antibodies in myasthenia gravis: mining physiological T cell homeostasis for TCR specific therapy. Jambou F; Cohen-Kaminsky S Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):181-92. PubMed ID: 12887101 [TBL] [Abstract][Full Text] [Related]
31. [Preliminary studies of T lymphocyte subsets in patients with neurologic diseases]. Cao L Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):159-61, 190. PubMed ID: 2143977 [TBL] [Abstract][Full Text] [Related]
32. How the immune system achieves self-nonself discrimination during adaptive immunity. Jiang H; Chess L Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1. Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363 [TBL] [Abstract][Full Text] [Related]
34. Immunologic and genetic factors in autoimmune diseases. Shoenfeld Y; Schwartz RS N Engl J Med; 1984 Oct; 311(16):1019-29. PubMed ID: 6384779 [No Abstract] [Full Text] [Related]
35. The thymus and myasthenia gravis. Ragheb S; Lisak RP Chest Surg Clin N Am; 2001 May; 11(2):311-27, x. PubMed ID: 11413758 [TBL] [Abstract][Full Text] [Related]
36. T cell subset abnormalities in tissue lesions developing during autoimmune disorders, viral infection, and graft-vs.-host disease. Janossy G; Montano L; Selby WS; Duke O; Panayi G; Lampert I; Thomas JA; Granger S; Bofill M; Tidman N; Thomas HC; Goldstein G J Clin Immunol; 1982 Jul; 2(3 Suppl):42S-56S. PubMed ID: 6290528 [TBL] [Abstract][Full Text] [Related]
37. Neuroimmunology. II: Antigenic specificity of the nervous system. Weiner HL; Hauser SL Ann Neurol; 1982 Dec; 12(6):499-509. PubMed ID: 6186183 [TBL] [Abstract][Full Text] [Related]
38. [Prospects and progress in the studies of neuroimmunology]. Igata A Nihon Rinsho; 1983; 41(4):784-8. PubMed ID: 6350648 [No Abstract] [Full Text] [Related]
39. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis. Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656 [TBL] [Abstract][Full Text] [Related]
40. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases]. Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]